One method is to hope that the plaintiffs die:
Wall Street now believes Merck’s ultimate Vioxx liability is closer to $5 billion than $25 billion, Lehman Brothers analyst Tony Butler adds. The reasoning – with fewer than 20 lawsuits so far making it to trial, some plaintiffs won’t live long enough to see any money.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
